Need For Long-Term CV Studies Goes Beyond COX-2s – Celebrex Study Authors

Regulatory authorities should request long-term cardiovascular safety studies for any new drug that may be used in high-risk patients in light of the COX-2 safety signals, authors of aCelebrex study state